⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QNTM News
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
Quantum BioPharma Ltd. Responds to Vague and Misleading Allegations by The Schall Law Firm and DJS Law Group
globenewswire.com
QNTM
Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock
globenewswire.com
QNTM
Quantum BioPharma: Engineering the Digital Balance Sheet in Life Sciences A Vanderbilt Report View
accessnewswire.com
QNTM
Quantum BioPharma Announces the Record Date for the Distribution of a Special Dividend of Contingent Value Rights (CVRs) Tied to the Future Litigation Settlement Proceeds of its USD $700 Million+ Case
globenewswire.com
QNTM
Quantum BioPharma Receives Final Reports for Two Key Studies of its Potential Breakthrough Drug for Multiple Sclerosis, Moving Closer to Phase 2 Clinical Trial
globenewswire.com
QNTM
Quantum BioPharma Welcomes World-Renowned Multiple Sclerosis Expert Dr. Jack Antel as Clinical Development Advisor For Lucid-MS Trials
globenewswire.com
QNTM
Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders
globenewswire.com
QNTM